A detailed history of Clear Creek Financial Management, LLC transactions in Femasys Inc stock. As of the latest transaction made, Clear Creek Financial Management, LLC holds 306,624 shares of FEMY stock, worth $343,418. This represents 0.04% of its overall portfolio holdings.

Number of Shares
306,624
Previous 317,474 3.42%
Holding current value
$343,418
Previous $361,000 5.82%
% of portfolio
0.04%
Previous 0.04%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$0.86 - $1.2 $9,331 - $13,020
-10,850 Reduced 3.42%
306,624 $340,000
Q2 2024

Jul 25, 2024

BUY
$0.96 - $1.81 $7,872 - $14,842
8,200 Added 2.65%
317,474 $361,000
Q1 2024

Apr 26, 2024

BUY
$0.75 - $2.22 $54,378 - $160,961
72,505 Added 30.62%
309,274 $479,000
Q4 2023

Jan 23, 2024

BUY
$0.76 - $3.89 $3,230 - $16,532
4,250 Added 1.83%
236,769 $232,000
Q3 2023

Oct 23, 2023

BUY
$0.31 - $2.98 $2,861 - $27,505
9,230 Added 4.13%
232,519 $692,000
Q2 2023

Jul 14, 2023

BUY
$0.51 - $1.26 $800 - $1,978
1,570 Added 0.71%
223,289 $113,000
Q1 2023

Apr 20, 2023

BUY
$0.85 - $1.29 $10,625 - $16,125
12,500 Added 5.97%
221,719 $239,000
Q4 2022

Jan 23, 2023

BUY
$0.83 - $1.41 $47,615 - $80,888
57,368 Added 37.78%
209,219 $0
Q3 2022

Oct 24, 2022

BUY
$1.13 - $2.54 $1,186 - $2,667
1,050 Added 0.7%
151,851 $172,000
Q2 2022

Jul 27, 2022

BUY
$1.3 - $2.76 $83,850 - $178,020
64,500 Added 74.74%
150,801 $363,000
Q1 2022

May 02, 2022

BUY
$1.76 - $3.99 $31,724 - $71,919
18,025 Added 26.4%
86,301 $195,000
Q4 2021

Jan 21, 2022

BUY
$3.49 - $8.02 $156,184 - $358,911
44,752 Added 190.24%
68,276 $266,000
Q3 2021

Oct 14, 2021

BUY
$6.52 - $8.5 $153,376 - $199,954
23,524 New
23,524 $162,000

Others Institutions Holding FEMY

About FEMASYS INC


  • Ticker FEMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 11,813,600
  • Market Cap $13.2M
  • Description
  • Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support...
More about FEMY
Track This Portfolio

Track Clear Creek Financial Management, LLC Portfolio

Follow Clear Creek Financial Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Creek Financial Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clear Creek Financial Management, LLC with notifications on news.